Biocryst Pharmaceuticals Inc(BCRX)
10.63
Change: -0.46 (▼ -4.36%)
As of Tue 12/20/2022 08:48 AM% Of Value
Growth
Value Per Share
:
:
:
-406.21
782.38
-2.0600 (as of 19/12/2022)
Fundamentals Data
| Open | 10.96 | Dividend | 67 |
| Close Price | 10.63 | DivYield | 0 % |
| High | 11.06 | Growth | 139.3 M |
| Low | 10.51 | Growth% | 782.38 |
| P/e | -8.912 | Volume | 2.3 M |
| P/b | -0.98 | Market Capital | 1.8 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 12.63 (as of 20/12/2022) | 50 Days Moving Average Percentage | -16.802960222017 (as of 20/12/2022 |
| Industry: Biotechnology: Biological Products (No Diagnostic Substances) |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 25.1 M | 20.6 M | 48.8 M | 17.8 M | 157.1 M |
| Cap Spending | -316,000.0 | -366,000.0 | -343,000.0 | -514,000.0 | -2.3 M |
| Operating Expenses | 80.8 M | 114.4 M | 144.1 M | 190.8 M | 327.6 M |
| Operating Cash Flow | -57.4 M | -94.2 M | -99.4 M | -174.7 M | -177.7 M |
| Free Cash Flow | -41.4 M | -92.9 M | -89.9 M | -137.7 M | -144.5 M |
| Free Cash Flow Per Share | -0.491 | -0.901 | -0.778 | -0.823 | -0.807 |
| Total liabilities | 54.7 M | 61.8 M | 84.6 M | 279.5 M | 593.2 M |
| Total cash | 53.5 M | 28.2 M | 115.7 M | 274.3 M | 507.7 M |
| ROE% | -1.065 | -1.758 | -42.237 | -7.736 | 1.692 |
| Outstanding Shares | 98.6 M | 110.1 M | 154.1 M | 177.1 M | 184.6 M |
| P/E | -8.394 | -8.912 | -3.129 | -11.611 | -16.664 |
| P/S | 21.925 | 43.691 | 6.978 | 119.17 | 19.515 |
| Revenue USD | 25.1 M | 20.6 M | 48.8 M | 17.8 M | 157.1 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|